Literature DB >> 8243529

The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation.

E Dimény1, G Tufveson, H Lithell, E Larsson, A Siegbahn, B Fellström.   

Abstract

Lipoprotein patterns were investigated before and after renal transplantation in a prospective study including 151 patients. Kidney graft losses during the first 6 months were associated with higher total cholesterol (P = 0.03), LDL cholesterol (P = 0.003) and LDL triglyceride levels (P = 0.01) before transplantation. Patients with serum cholesterol > or = 6.9 mmol l-1 before transplantation had more acute rejections (1.7 vs. 0.9), a worse graft function and more vascular intimal hyperplasia and glomerular mesangial changes in transplant biopsies at 6 months. Patients with serum creatinine levels exceeding 160 mumol l-1 at 6 months had more severe lipid disorders already before transplantation. Serum creatinine at 6 months was influenced by the number of acute rejection episodes (P = 0.0001) and the age of the donor (P = 0.009) while the number of acute rejections was found to be related to pretransplant total cholesterol levels (P = 0.0086) and the age of the recipient (P = 0.025). In conclusion, pretransplant lipoprotein disturbances have an impact on the early outcome of renal transplantation. Since there is a progression of hyperlipidaemia following transplantation, this may have an influence also on the cardiovascular morbidity and late graft dysfunction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243529     DOI: 10.1111/j.1365-2362.1993.tb00968.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Lipoprotein-apolipoprotein changes in renal transplant recipients.

Authors:  Maurizio Cassader; Gianluca Ruiu; Roberto Gambino; Natalina Alemanno; Giorgio Triolo; Fabrizio Veglia; Gianfranco Pagano
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

2.  Dyslipidaemia and hyperlipidaemia following renal transplantation.

Authors:  L Lócsey; L Asztalos; Z Kincses; F Gyórfi; C Berczi
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Urinary proteomic analysis of chronic allograft nephropathy.

Authors:  Edmond O'Riordan; Tatyana N Orlova; Natalia Mendelev; Daniel Patschan; Rowena Kemp; Praveen N Chander; Rena Hu; Gang Hao; Steven S Gross; Renato V Iozzo; Veronica Delaney; Michael S Goligorsky
Journal:  Proteomics Clin Appl       Date:  2008-07       Impact factor: 3.494

4.  Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis.

Authors:  A J McLaren; S V Fuggle; K I Welsh; D W Gray; P J Morris
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

Review 5.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  The pathogenesis and treatment of chronic allograft nephropathy.

Authors:  Can Li; Chul Woo Yang
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

7.  Diet-induced increase in plasma oxidized LDL promotes early fibrosis in a renal porcine auto-transplantation model.

Authors:  Nicolas Chatauret; Frédéric Favreau; Sebastien Giraud; Antoine Thierry; Ludivine Rossard; Sylvain Le Pape; Lilach O Lerman; Thierry Hauet
Journal:  J Transl Med       Date:  2014-03-22       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.